What question did this study set out to answer?

This research aims to identify reliable prognostic biomarkers associated with non-small cell lung cancer after chemoradiotherapy.

April 22, 2026The Analyst0 citations

Quantitative Metabolomics Identifies Prognostic Biomarkers Associated with NSCLC after chemoradiotherapy

YLYuan LeiruiState Ethnic Affairs Commission LWLinfang WuSun Yat-sen University MQMingmin QianState Ethnic Affairs Commission

Key Points

This research aims to identify reliable prognostic biomarkers associated with non-small cell lung cancer after chemoradiotherapy.
Conducted quantitative metabolomics analysis on NSCLC samples post-chemoradiotherapy.
Evaluated individual variability and its influence on treatment outcomes.
Identified specific biomarkers that correlate with treatment response in NSCLC.
Demonstrated the potential for these biomarkers to enhance precision therapy approaches.

Abstract

Introduction: The high mortality of non-small cell lung cancer (NSCLC) is influenced by pre-treatment individual variability, yet reliable prognostic biomarkers are lacking, hindering precision therapy.Objectives: This study aimed to identify...

AI에게 질문

Bookmark

View Full Paper